These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 35280662)
21. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320 [TBL] [Abstract][Full Text] [Related]
22. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X Front Immunol; 2022; 13():934387. PubMed ID: 35958561 [TBL] [Abstract][Full Text] [Related]
23. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma. Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F Front Genet; 2022; 13():978840. PubMed ID: 36186442 [TBL] [Abstract][Full Text] [Related]
24. Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma. Xin S; Sun X; Jin L; Zhou Z; Liu X; Li W; Mei W; Zhang J; Zhang B; Yao X; Zhou L; Ye L J Oncol; 2022; 2022():9498010. PubMed ID: 35342405 [TBL] [Abstract][Full Text] [Related]
25. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis. Cui Y; Zhou Z; Chai Y; Zhang Y J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313 [TBL] [Abstract][Full Text] [Related]
26. A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma. Dong P; Zhao L; Zhao L; Zhang J; Lu G; Zhang H; Ma M Transl Cancer Res; 2024 Jan; 13(1):249-267. PubMed ID: 38410237 [TBL] [Abstract][Full Text] [Related]
27. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma. Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048 [TBL] [Abstract][Full Text] [Related]
28. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma. Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721 [TBL] [Abstract][Full Text] [Related]
29. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. Chen CC; Chu PY; Lin HY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154 [TBL] [Abstract][Full Text] [Related]
30. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Sun M; Qi S; Wu M; Xia W; Xiong H Front Genet; 2022; 13():909556. PubMed ID: 36338983 [No Abstract] [Full Text] [Related]
31. Decreased expression of Liu W; Xiao Z; Dong M; Li X; Huang Z Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038 [TBL] [Abstract][Full Text] [Related]
32. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma. Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541 [TBL] [Abstract][Full Text] [Related]
33. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma. Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G Front Genet; 2022; 13():922358. PubMed ID: 35812727 [No Abstract] [Full Text] [Related]
34. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis. Zhao YW; Ma W; Jiang F; Xie Y; Tang L Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474 [TBL] [Abstract][Full Text] [Related]
35. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
36. A Novel Gene Signature of Tripartite Motif Family for Predicting the Prognosis in Kidney Renal Clear Cell Carcinoma and Its Association With Immune Cell Infiltration. Zheng D; Zhang Y; Xia Y; Cheng F Front Oncol; 2022; 12():840410. PubMed ID: 35371994 [TBL] [Abstract][Full Text] [Related]
37. A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma. Xie W; Xi P; Liu Y; Zhang Z; Sun T Front Pharmacol; 2022; 13():1002588. PubMed ID: 36299888 [No Abstract] [Full Text] [Related]
38. Identification of a Necroptosis-Related Prognostic Index and Associated Regulatory Axis in Kidney Renal Clear Cell Carcinoma. Luo Y; Zhang G Int J Gen Med; 2022; 15():5407-5423. PubMed ID: 35685693 [TBL] [Abstract][Full Text] [Related]
39. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q Front Genet; 2022; 13():862210. PubMed ID: 35903358 [No Abstract] [Full Text] [Related]
40. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma. Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X Front Oncol; 2020; 10():570819. PubMed ID: 33628726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]